Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2016, Article ID 8512721, 10 pages
http://dx.doi.org/10.1155/2016/8512721
Case Report

Hyperammonemia: What Urea-lly Need to Know: Case Report of Severe Noncirrhotic Hyperammonemic Encephalopathy and Review of the Literature

1Department of Neurological Sciences, Rush University Medical Center, 1725 West Harrison Street, POB Suite 1121, Chicago, IL 60612, USA
2Rush Medical College, Rush University Medical Center, 600 S. Paulina Street, Chicago, IL 60612, USA
3Department of Neurology, Division of Neurocritical Care, University of Florida, McKnight Brain Institute, Room L3-100, 1149 Newell Drive, Gainesville, FL 32611, USA

Received 13 July 2016; Accepted 28 August 2016

Academic Editor: Piotr K. Janicki

Copyright © 2016 Ruby Upadhyay et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Ferenci, “Brain dysfunction in fulminant hepatic failure,” Journal of Hepatology, vol. 21, no. 4, pp. 487–490, 1994. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Cichoz-Lach and A. Michalak, “Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy,” World Journal of Gastroenterology, vol. 19, no. 1, pp. 26–34, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Caldovic, I. Abdikarim, S. Narain, M. Tuchman, and H. Morizono, “Genotype-phenotype correlations in ornithine transcarbamylase deficiency: a mutation update,” Journal of Genetics and Genomics, vol. 42, no. 5, pp. 181–194, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. S. W. M. Olde Damink, R. Jalan, and C. H. C. Dejong, “Interorgan ammonia trafficking in liver disease,” Metabolic Brain Disease, vol. 24, no. 1, pp. 169–181, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. A. S. Clay and B. E. Hainline, “Hyperammonemia in the ICU,” Chest, vol. 132, no. 4, pp. 1368–1378, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. W. R. Treem, “Inherited and acquired syndromes of hyperammonemia and encephalopathy in children,” Seminars in Liver Disease, vol. 14, no. 3, pp. 236–258, 1994. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Ott and H. Vilstrup, “Cerebral effects of ammonia in liver disease: current hypotheses,” Metabolic Brain Disease, vol. 29, no. 4, pp. 901–911, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. W. Raabe, “Ammonium ions abolish excitatory synaptic transmission between cerebellar neurons in primary dissociated tissue culture,” Journal of Neurophysiology, vol. 68, no. 1, pp. 93–99, 1992. View at Google Scholar · View at Scopus
  9. J. E. Fischer, N. Yoshimura, A. Aguirre et al., “Plasma amino acids in patients with hepatic encephalopathy. Effects of amino acid infusions,” The American Journal of Surgery, vol. 127, no. 1, pp. 40–47, 1974. View at Publisher · View at Google Scholar · View at Scopus
  10. A. T. Blei, S. Olafsson, G. Therrien, and R. F. Butterworth, “Ammonia-induced brain edema and intracranial hypertension in rats after portacaval anastomosis,” Hepatology, vol. 19, no. 6, pp. 1437–1444, 1994. View at Publisher · View at Google Scholar · View at Scopus
  11. A. T. Blei and F. S. Larsen, “Pathophysiology of cerebral edema in fulminant hepatic failure,” Journal of Hepatology, vol. 31, no. 4, pp. 771–776, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Hertz and G. Kala, “Energy metabolism in brain cells: effects of elevated ammonia concentrations,” Metabolic Brain Disease, vol. 22, no. 3-4, pp. 199–218, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Kwan, C. Wang, and L. Levitt, “Hyperammonemic encephalopathy in multiple myeloma,” The New England Journal of Medicine, vol. 346, no. 21, pp. 1674–1675, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Otsuki, O. Yamada, H. Sakaguchi et al., “In vitro excess ammonia production in human myeloma cell lines,” Leukemia, vol. 12, no. 7, pp. 1149–1158, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. R. B. Mitchell, J. E. Wagner, J. E. Karp et al., “Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine cases,” The American Journal of Medicine, vol. 85, no. 5, pp. 662–667, 1988. View at Publisher · View at Google Scholar · View at Scopus
  16. S. M. Davies, E. Szabo, J. E. Wagner, N. K. C. Ramsay, and D. J. Weisdorf, “Idiopathic hyperammonemia: a frequently lethal complication of bone marrow transplantation,” Bone Marrow Transplantation, vol. 17, no. 6, pp. 1119–1125, 1996. View at Google Scholar · View at Scopus
  17. G. R. Lichtenstein, Y.-X. Yang, F. A. Nunes et al., “Fatal hyperammonemia after orthotopic lung transplantation,” Annals of Internal Medicine, vol. 132, no. 4, pp. 283–287, 2000. View at Google Scholar · View at Scopus
  18. E. M. Yoshida, D. N. Ostrow, S. R. Erb, and G. Fradet, “Hyperammonemia after heart-lung transplantation,” Gastroenterology, vol. 112, no. 6, p. 2162, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. M. del Rosario, S. L. Werlin, and S. J. Lauer, “Hyperammonemic encephalopathy after chemotherapy: survival after treatment with sodium benzoate and sodium phenylacetate,” Journal of Clinical Gastroenterology, vol. 25, no. 4, pp. 682–684, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. K. H. Metzeler, S. Boeck, B. Christ et al., “Idiopathic hyperammonemia (IHA) after dose-dense induction chemotherapy for acute myeloid leukemia: case report and review of the literature,” Leukemia Research, vol. 33, no. 7, pp. e69–e72, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. H.-K. Cheang, L. Rangecroft, N. D. Plant, and A. A. M. Morris, “Hyperammonaemia due to Klebsiella infection in a neuropathic bladder,” Pediatric Nephrology, vol. 12, no. 8, pp. 658–659, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. D. A. Diamond, A. Blight, and P. G. Ransley, “Hyperammonemic encephalopathy: a complication associated with the prune belly syndrome,” The Journal of Urology, vol. 142, no. 2, part 1, pp. 361–362, 1989. View at Google Scholar · View at Scopus
  23. B. Samtoy and M. M. DeBeukelaer, “Ammonia encephalopathy secondary to urinary tract infection with Proteus mirabilis,” Pediatrics, vol. 65, no. 2, pp. 294–297, 1980. View at Google Scholar · View at Scopus
  24. B. De Jonghe, V. Janier, N. Abderrahim, D. Hillion, J.-C. Lacherade, and H. Outin, “Urinary tract infection and coma,” The Lancet, vol. 360, no. 9338, p. 996, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. P. M. Barnes, D. B. Wheldon, C. Eggerding, W. C. Marshall, and J. V. Leonard, “Hyperammonaemia and disseminated herpes simplex infection in the neonatal period,” The Lancet, vol. 319, no. 8285, pp. 1362–1363, 1982. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Nurmohamed, A. Weenink, H. Moeniralam, C. Visser, and F. Bemelman, “Hyperammonemia in generalized Mycobacterium genavense infection after renal transplantation,” American Journal of Transplantation, vol. 7, no. 3, pp. 722–723, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. M. E. Wylam, C. C. Kennedy, N. M. Hernandez et al., “Fatal hyperammonaemia caused by Mycoplasma hominis,” The Lancet, vol. 382, no. 9908, p. 1956, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. N. D. Hawkes, G. A. O. Thomas, A. Jurewicz et al., “Non-hepatic hyperammonaemia: an important, potentially reversible cause of encephalopathy,” Postgraduate Medical Journal, vol. 77, no. 913, pp. 717–722, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. M. L. Summar, F. Barr, S. Dawling et al., “Unmasked adult-onset urea cycle disorders in the critical care setting,” Critical Care Clinics, vol. 21, no. 4, pp. S1–S8, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. D. M. Felig, S. W. Brusilow, and J. L. Boyer, “Hyperammonemic coma due to parenteral nutrition in a woman with heterozygous ornithine transcarbamylase deficiency,” Gastroenterology, vol. 109, no. 1, pp. 282–284, 1995. View at Publisher · View at Google Scholar · View at Scopus
  31. R. E. Grazer, J. M. Sutton, S. Friedstrom, and F. D. McBarron, “Hyperammonemic encephalopathy due to essential amino acid hyperalimentation,” Archives of Internal Medicine, vol. 144, no. 11, pp. 2278–2279, 1984. View at Publisher · View at Google Scholar · View at Scopus
  32. I. Laish and Z. Ben Ari, “Noncirrhotic hyperammonaemic encephalopathy,” Liver International, vol. 31, no. 9, pp. 1259–1270, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. S. W. Brusilow and N. E. Maestri, “Urea cycle disorders: diagnosis, pathophysiology, and therapy,” Advances in Pediatrics, vol. 43, pp. 127–170, 1996. View at Google Scholar
  34. B. K. Burton, “Urea cycle disorders,” Clinics in Liver Disease, vol. 4, no. 4, pp. 815–830, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. J. A. Arranz, E. Riudor, C. Marco-Marín, and V. Rubio, “Estimation of the total number of disease-causing mutations in ornithine transcarbamylase (OTC) deficiency. Value of the OTC structure in predicting a mutation pathogenic potential,” Journal of Inherited Metabolic Disease, vol. 30, no. 2, pp. 217–226, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. P. H. Arn, E. R. Hauser, G. H. Thomas, G. Herman, D. Hess, and S. W. Brusilow, “Hyperammonemia in women with a mutation at the ornithine carbamoyltransferase locus—a cause of postpartum coma,” The New England Journal of Medicine, vol. 322, no. 23, pp. 1652–1655, 1990. View at Publisher · View at Google Scholar · View at Scopus
  37. Z. Ben-Ari, A. Dalal, A. Morry et al., “Adult-onset ornithine transcarbamylase (OTC) deficiency unmasked by the Atkins' diet,” Journal of Hepatology, vol. 52, no. 2, pp. 292–295, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. O. Elpeleg, A. Shaag, E. Ben-Shalom, T. Schmid, and C. Bachmann, “N-acetylglutamate synthase deficiency and the treatment of hyperammonemic encephalopathy,” Annals of Neurology, vol. 52, no. 6, pp. 845–849, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. W. D. Lo, H. R. Sloan, J. F. Sotos, and R. J. Klinger, “Late clinical presentation of partial carbamyl phosphate synthetase I deficiency,” American Journal of Diseases of Children, vol. 147, no. 3, pp. 267–269, 1993. View at Google Scholar · View at Scopus
  40. F. Ishikawa, M. Nakamuta, M. Kato et al., “Reversibility of serum NH3 level in a case of sudden onset and rapidly progressive case of type 2 citrullinemia,” Internal Medicine, vol. 39, no. 11, pp. 925–929, 2000. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Trivedi, S. Zafar, M. J. Spalding, and S. Jonnalagadda, “Ornithine transcarbamylase deficiency unmasked because of gastrointestinal bleeding,” Journal of Clinical Gastroenterology, vol. 32, no. 4, pp. 340–343, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. D. Honeycutt, K. Callahan, L. Rutledge, and B. K. Evans, “Heterozygote ornithine transcarbamylase deficiency presenting as symptomatic hyperammonemia during initiation of valproate therapy,” Neurology, vol. 42, no. 3, part 1, pp. 666–668, 1992. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Uchino, I. Matsuda, and F. Endo, “The long-term prognosis of congenital portosystemic venous shunt,” The Journal of Pediatrics, vol. 135, no. 2, part 1, pp. 254–256, 1999. View at Publisher · View at Google Scholar · View at Scopus
  44. S. K. Yadav, A. Srivastava, A. Srivastava et al., “Encephalopathy assessment in children with extra-hepatic portal vein obstruction with MR, psychometry and critical flicker frequency,” Journal of Hepatology, vol. 52, no. 3, pp. 348–354, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. A. R. Mundy, “Metabolic complications of urinary diversion,” The Lancet, vol. 353, no. 9167, pp. 1813–1814, 1999. View at Publisher · View at Google Scholar · View at Scopus
  46. W. S. McDougal, “Metabolic complications of urinary intestinal diversion,” The Journal of Urology, vol. 147, no. 5, pp. 1199–1208, 1992. View at Google Scholar · View at Scopus
  47. E. Mortensen, G. Lyng, E. Juhl, J. Egense, and M. Schwartz, “Ammonia-induced coma after ureterosigmoidostomy,” The Lancet, vol. 299, no. 7758, p. 1024, 1972. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Verrotti, D. Trotta, G. Morgese, and F. Chiarelli, “Valproate-induced hyperammonemic encephalopathy,” Metabolic Brain Disease, vol. 17, no. 4, pp. 367–373, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. G. Ambrosetto, R. Riva, and A. Baruzzi, “Hyperammonemia in asterixis induced by carbamazepine: two case reports,” Acta Neurologica Scandinavica, vol. 69, no. 3, pp. 186–189, 1984. View at Publisher · View at Google Scholar · View at Scopus
  50. G. Sekas and H. S. Paul, “Hyperammonemia and carnitine deficiency in a patient receiving sulfadiazine and pyrimethamine,” The American Journal of Medicine, vol. 95, no. 1, pp. 112–113, 1993. View at Publisher · View at Google Scholar · View at Scopus
  51. P. Bertrand, A. Faro, P. Cantwell, and A. Tzakis, “Intravenous ribavirin and hyperammonemia in an immunocompromised patient infected with adenovirus,” Pharmacotherapy, vol. 20, no. 10, pp. 1216–1220, 2000. View at Publisher · View at Google Scholar · View at Scopus
  52. A. L. Makela, H. Lang, and P. Korpela, “Toxic encephalopathy with hyperammonaemia during high-dose salicylate therapy,” Acta Neurologica Scandinavica, vol. 61, no. 3, pp. 146–156, 1980. View at Google Scholar · View at Scopus
  53. K. W. Ryder, J. F. Olson, R. J. Kahnoski, R. C. Karn, and T. O. Oei, “Hyperammonemia after transurethral resection of the prostate: a report of 2 cases,” The Journal of Urology, vol. 132, no. 5, pp. 995–997, 1984. View at Google Scholar · View at Scopus
  54. J. V. Murphy and K. Marquardt, “Asymptomatic hyperammonemia in patients receiving valproic acid,” Archives of Neurology, vol. 39, no. 9, pp. 591–592, 1982. View at Publisher · View at Google Scholar · View at Scopus
  55. M.-J. C. C. Dealberto, “Valproate-induced hyperammonaemic encephalopathy: review of 14 cases in the psychiatric setting,” International Clinical Psychopharmacology, vol. 22, no. 6, pp. 330–337, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. T. Gerstner, D. Buesing, E. Longin et al., “Valproic acid induced encephalopathy—19 new cases in Germany from 1994 to 2003—a side effect associated to VPA-therapy not only in young children,” Seizure, vol. 15, no. 6, pp. 443–448, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. G. N. Breningstall, “Neurologic syndromes in hyperammonemic disorders,” Pediatric Neurology, vol. 2, no. 5, pp. 253–262, 1986. View at Publisher · View at Google Scholar · View at Scopus
  58. J. Vaquero, C. Chung, M. E. Cahill, and A. T. Blei, “Pathogenesis of hepatic encephalopathy in acute liver failure,” Seminars in Liver Disease, vol. 23, no. 3, pp. 259–269, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. J. O. Clemmesen, F. S. Larsen, J. Kondrup, B. A. Hansen, and P. Ott, “Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration,” Hepatology, vol. 29, no. 3, pp. 648–653, 1999. View at Publisher · View at Google Scholar · View at Scopus
  60. J. P. Ong, A. Aggarwal, D. Krieger et al., “Correlation between ammonia levels and the severity of hepatic encephalopathy,” American Journal of Medicine, vol. 114, no. 3, pp. 188–193, 2003. View at Publisher · View at Google Scholar · View at Scopus
  61. L. Kramer, B. Tribl, A. Gendo et al., “Partial pressure of ammonia versus ammonia in hepatic encephalopathy,” Hepatology, vol. 31, no. 1, pp. 30–34, 2000. View at Publisher · View at Google Scholar · View at Scopus
  62. G. F. Hoffman, W. L. Nyhan, J. Zschocke, S. G. Kahler, and E. Mayatepek, Inherited Metabolic Disease, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2002.
  63. A. N. Rao, P. Varma, Sumitra, and S. Dhanya, “Hyperammonemia: diagnostic experience at the metabolism laboratory,” The Internet Journal of Laboratory Medicine, vol. 1, no. 2, 2005. View at Google Scholar
  64. A. Watanabe, “Portal-systemic encephalopathy in non-cirrhotic patients: classification of clinical types, diagnosis and treatment,” Journal of Gastroenterology and Hepatology, vol. 15, no. 9, pp. 969–979, 2000. View at Publisher · View at Google Scholar · View at Scopus
  65. A. de Havenon, K. French, and S. Ansari, “Extensive cortical diffusion restriction in a 50-year-old female with hyperammonemic encephalopathy and status epilepticus,” Case Reports in Neurological Medicine, vol. 2014, Article ID 257094, 4 pages, 2014. View at Publisher · View at Google Scholar
  66. J. M. U-King-Im, E. Yu, E. Bartlett, R. Soobrah, and W. Kucharczyk, “Acute hyperammonemic encephalopathy in adults: imaging findings,” American Journal of Neuroradiology, vol. 32, no. 2, pp. 413–418, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Rosario, K. McMahon, and P. F. Finelli, “Diffusion-weighted imaging in acute hyperammonemic encephalopathy,” The Neurohospitalist, vol. 3, no. 3, pp. 125–130, 2013. View at Publisher · View at Google Scholar
  68. J.-I. Takanashi, A. J. Barkovich, S. F. Cheng et al., “Brain MR imaging in neonatal hyperammonemic encephalopathy resulting from proximal urea cycle disorders,” American Journal of Neuroradiology, vol. 24, no. 6, pp. 1184–1187, 2003. View at Google Scholar · View at Scopus
  69. A. Kawata, M. Suda, and H. Tanabe, “Adult-onset type II citrullinemia: clinical pictures before and after liver transplantation,” Internal Medicine, vol. 36, no. 6, pp. 408–412, 1997. View at Publisher · View at Google Scholar · View at Scopus
  70. B. Als-Nielsen, L. L. Gluud, and C. Gluud, “Nonabsorbable disaccharides for hepatic encephalopathy,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD003044, 2004. View at Google Scholar · View at Scopus
  71. M. I. Nevah and M. B. Fallon, “Hepatic encephalopathy, hepatorenal syndrome, hepatopulmonary syndrome and systemic complications of liver disease,” in Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management, M. Feldman, L. S. Friedman, and L. J. Brandt, Eds., pp. 1543–1555, Saunders, Elsevier, Philadelphia, Pa, USA, 9th edition, 2010. View at Google Scholar
  72. N. M. Bass, K. D. Mullen, A. Sanyal et al., “Rifaximin treatment in hepatic encephalopathy,” The New England Journal of Medicine, vol. 362, no. 12, pp. 1071–1081, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. S. M. Donn, R. D. Swartz, and J. G. Thoene, “Comparison of exchange transfusion, peritoneal dialysis, and hemodialysis for the treatment of hyperammonemia in an anuric newborn infant,” The Journal of Pediatrics, vol. 95, no. 1, pp. 67–70, 1979. View at Publisher · View at Google Scholar · View at Scopus
  74. V. Mohsenin, “Assessment and management of cerebral edema and intracranial hypertension in acute liver failure,” Journal of Critical Care, vol. 28, no. 5, pp. 783–791, 2013. View at Publisher · View at Google Scholar · View at Scopus
  75. V. A. Saraswat, S. Saksena, K. Nath et al., “Evaluation of mannitol effect in patients with acute hepatic failure and acute-on-chronic liver failure using conventional MRI, diffusion tensor imaging and in-vivo proton MR spectroscopy,” World Journal of Gastroenterology, vol. 14, no. 26, pp. 4168–4178, 2008. View at Publisher · View at Google Scholar · View at Scopus
  76. E. M. Liotta, B. D. Lizza, A. L. Romanova et al., “23.4% Saline decreases brain tissue volume in severe hepatic encephalopathy as assessed by a quantitative CT marker,” Critical Care Medicine, vol. 44, no. 1, pp. 171–179, 2016. View at Publisher · View at Google Scholar · View at Scopus
  77. L. C. Wendell, A. Khan, J. Raser et al., “Successful management of refractory intracranial hypertension from acute hyperammonemic encephalopathy in a woman with ornithine transcarbamylase deficiency,” Neurocritical Care, vol. 13, no. 1, pp. 113–117, 2010. View at Publisher · View at Google Scholar · View at Scopus
  78. S. Kodali and B. M. McGuire, “Diagnosis and management of hepatic encephalopathy in fulminant hepatic failure,” Clinics in Liver Disease, vol. 19, no. 3, pp. 565–576, 2015. View at Publisher · View at Google Scholar · View at Scopus
  79. C. J. Karvellas, O. K. Fix, H. Battenhouse, V. Durkalski, C. Sanders, and W. M. Lee, “Outcomes and complications of intracranial pressure monitoring in acute liver failure: a retrospective cohort study,” Critical Care Medicine, vol. 42, no. 5, pp. 1157–1167, 2014. View at Publisher · View at Google Scholar · View at Scopus
  80. R. M. Cohn and K. S. Roth, “Hyperammonemia, bane of the brain,” Clinical Pediatrics, vol. 43, no. 8, pp. 683–689, 2004. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Malaguarnera, G. Pistone, M. Astuto et al., “L-Carnitine in the treatment of mild or moderate hepatic encephalopathy,” Digestive Diseases, vol. 21, no. 3, pp. 271–275, 2003. View at Publisher · View at Google Scholar · View at Scopus
  82. Y. Ohtani, K. Ohyanagi, S. Yamamoto, and I. Matsuda, “Secondary carnitine deficiency in hyperammonemic attacks of ornithine transcarbamylase deficiency,” The Journal of Pediatrics, vol. 112, no. 3, pp. 409–414, 1988. View at Publisher · View at Google Scholar · View at Scopus
  83. M. F. Camiña, I. Rozas, M. Castro-Gago, J. M. Paz, C. Alonso, and S. Rodriguez-Segade, “Alteration of renal carnitine metabolism by anticonvulsant treatment,” Neurology, vol. 41, no. 9, pp. 1444–1448, 1991. View at Publisher · View at Google Scholar · View at Scopus
  84. T. P. Bohan, E. Helton, I. McDonald et al., “Effect of L-carnitine treatment for valproate-induced hepatotoxicity,” Neurology, vol. 56, no. 10, pp. 1405–1409, 2001. View at Publisher · View at Google Scholar · View at Scopus
  85. Q. Jiang, X.-H. Jiang, M.-H. Zheng, and Y.-P. Chen, “L-Ornithine-L-aspartate in the management of hepatic encephalopathy: a meta-analysis,” Journal of Gastroenterology and Hepatology, vol. 24, no. 1, pp. 9–14, 2009. View at Publisher · View at Google Scholar · View at Scopus
  86. S. W. Brusilow, “Arginine, an indispensable amino acid for patients with inborn errors of urea synthesis,” Journal of Clinical Investigation, vol. 74, no. 6, pp. 2144–2148, 1984. View at Publisher · View at Google Scholar · View at Scopus
  87. D. Morioka, M. Kasahara, Y. Takada et al., “Current role of liver transplantation for the treatment of urea cycle disorders: a review of the worldwide English literature and 13 cases at Kyoto University,” Liver Transplantation, vol. 11, no. 11, pp. 1332–1342, 2005. View at Publisher · View at Google Scholar · View at Scopus
  88. G. Morgan and R. Superina, “Congenital absence of the portal vein: two cases and a proposed classification system for portasystemic vascular anomalies,” Journal of Pediatric Surgery, vol. 29, no. 9, pp. 1239–1241, 1994. View at Publisher · View at Google Scholar · View at Scopus
  89. G. Acharya, S. Mehra, R. Patel, S. Frunza-Stefan, and H. Kaur, “Fatal nonhepatic hyperammonemia in ICU setting: a rare but serious complication following bariatric surgery,” Case Reports in Critical Care, vol. 2016, Article ID 8531591, 6 pages, 2016. View at Publisher · View at Google Scholar
  90. A. Açikalin, N. R. Dişel, E. Ç. Direk, M. T. Ilginel, A. Sebe, and Ş. Biçakçi, “A rare cause of postpartum coma: isolated hyperammonemia due to urea cycle disorder,” American Journal of Emergency Medicine, vol. 34, no. 7, pp. 1324.e3–1324.e4, 2016. View at Publisher · View at Google Scholar · View at Scopus
  91. M. Alameri, M. Shakra, and T. Alsaadi, “Fatal coma in a young adult due to late-onset urea cycle deficiency presenting with a prolonged seizure: a case report,” Journal of Medical Case Reports, vol. 9, no. 1, article 267, 2015. View at Publisher · View at Google Scholar · View at Scopus
  92. G. P. Bijvoet, C. J. van der Sijs-Bos, J. P. Wielders, and O. A. Groot, “Fatal hyperammonaemia due to late-onset ornithine transcarbamylase deficiency,” The Netherlands Journal of Medicine, vol. 74, no. 1, pp. 36–39, 2016. View at Google Scholar
  93. O. M. Panlaqui, K. Tran, A. Johns, J. McGill, and H. White, “Acute hyperammonemic encephalopathy in adult onset ornithine transcarbamylase deficiency,” Intensive Care Medicine, vol. 34, no. 10, pp. 1922–1924, 2008. View at Publisher · View at Google Scholar · View at Scopus
  94. T. Mahmood and K. Nugent, “Nonhepatic hyperammonemic encephalopathy due to undiagnosed urea cycle disorder,” Proceedings, vol. 28, no. 3, pp. 375–377, 2015. View at Google Scholar